Total Payments
$165,515
2024 Payments
$28,785
Companies
17
Transactions
269
Payment Breakdown by Category
Other$93,315 (56.4%)
Consulting$32,630 (19.7%)
Travel$31,080 (18.8%)
Food & Beverage$6,235 (3.8%)
Education$2,255 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $75,095 | 38 | 45.4% |
| Consulting Fee | $32,630 | 14 | 19.7% |
| Travel and Lodging | $31,080 | 46 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,220 | 11 | 11.0% |
| Food and Beverage | $6,235 | 94 | 3.8% |
| Education | $2,255 | 66 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $76,974 | 161 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $50,017 | 50 | $0 (2024) |
| Horizon Therapeutics plc | $10,840 | 5 | $0 (2023) |
| Retrophin, Inc. | $8,524 | 10 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $6,982 | 12 | $0 (2024) |
| Travere Therapeutics, Inc. | $5,004 | 16 | $0 (2024) |
| Mallinckrodt LLC | $3,011 | 2 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,640 | 1 | $0 (2024) |
| Novo Nordisk Inc | $460.00 | 1 | $0 (2022) |
| GENZYME CORPORATION | $243.95 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,785 | 32 | CALLIDITAS THERAPEUTICS US INC. ($19,084) |
| 2023 | $33,338 | 42 | Calliditas Therapeutics US Inc. ($26,787) |
| 2022 | $6,089 | 14 | CALLIDITAS THERAPEUTICS US INC. ($4,146) |
| 2021 | $5,421 | 7 | Travere Therapeutics, Inc. ($4,131) |
| 2020 | $21,129 | 23 | Alexion Pharmaceuticals, Inc. ($18,969) |
| 2019 | $9,511 | 14 | Retrophin, Inc. ($7,024) |
| 2018 | $17,939 | 31 | Alexion Pharmaceuticals, Inc. ($16,316) |
| 2017 | $43,302 | 106 | Alexion Pharmaceuticals, Inc. ($40,172) |
All Payment Transactions
269 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: Nephrology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $605.12 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $290.75 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $207.28 | General |
| 11/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $139.99 | General |
| 10/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 09/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 09/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $913.21 | General |
| Category: Nephrology | ||||||
| 09/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: Nephrology | ||||||
| 07/03/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $250.00 | General |
| Category: Nephrology | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 05/30/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Nephrology | ||||||
| 05/16/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/24/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $4,500.00 | General |
| Category: Nephrology | ||||||
| 04/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 04/02/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.28 | General |
| 03/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 03/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $179.64 | General |
| Category: Nephrology | ||||||
| 03/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $121.12 | General |
| Category: Nephrology | ||||||
| 03/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Nephrology | ||||||
| 03/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Nephrology | ||||||
| 03/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Nephrology | ||||||
| 03/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Nephrology | ||||||
| 03/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $310.94 | General |
| Category: Nephrology | ||||||
About Dr. Kenneth Lieberman, MD
Dr. Kenneth Lieberman, MD is a Pediatric Nephrology healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174582951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Lieberman, MD has received a total of $165,515 in payments from pharmaceutical and medical device companies, with $28,785 received in 2024. These payments were reported across 269 transactions from 17 companies. The most common payment nature is "Honoraria" ($75,095).
Ad
Practice Information
- Specialty Pediatric Nephrology
- Location Hackensack, NJ
- Active Since 03/21/2006
- Last Updated 09/30/2022
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1174582951
Products in Payments
- SOLIRIS (Drug) $54,260
- TARPEYO (Drug) $50,017
- PROCYSBI (Drug) $10,840
- Ultomiris (Drug) $8,105
- Soliris (Drug) $8,014
- ACTHAR (Biological) $3,011
- ULTOMIRIS (Biological) $1,000
- LUPKYNIS (Drug) $133.19
- Thiola (Drug) $128.69
- FABRAZYME (Drug) $123.66
- THYMOGLOBULIN (Biological) $121.07
- FABRAZYME (Biological) $120.29
- Rituxan (Biological) $120.00
- JYNARQUE (Drug) $105.39
- AFINITOR (Drug) $12.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.